title: Cost-effectiveness of universal influenza vaccination in a pregnant population.
abstract: OBJECTIVE
  The purpose of this study was to estimate whether universal influenza vaccination of pregnant women was cost-effective in the management of influenza-like illness during influenza season.
  
  
  METHODS
  A decision analysis model was developed to investigate the cost-effectiveness of providing inactivated trivalent influenza vaccine to all pregnant women. This scenario was compared with providing supportive care only on a case-by-case basis to the unvaccinated pregnant population.
  
  
  RESULTS
  Vaccination of 100% of pregnant women would save approximately 50 dollars per woman, resulting in a net gain of approximately 45 quality-adjusted hours relative to providing supportive care only.
  
  
  CONCLUSIONS
  Universal vaccination with inactivated trivalent influenza vaccine is cost-saving relative to providing supportive care alone in the pregnant population.
  
  
  METHODS
  III.
authors.affiliation: Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9032, USA scott.roberts@utsouthwestern.edu
authors.forename: Scott
authors.initials: S
authors.lastname: Roberts
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Hollier
authors.forename: Jeanne
authors.initials: J
authors.lastname: Sheffield
authors.forename: Vanessa
authors.initials: V
authors.lastname: Laibl
authors.forename: George D
authors.initials: GD
authors.lastname: Wendel
mesh_terms: D000293:Adolescent; D000328:Adult; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D017589:Immunization Programs / Q000191:economics*; D007252:Influenza Vaccines / Q000191:economics* / Q000600:supply & distribution; D007251:Influenza, Human / Q000191:economics / Q000517:prevention & control*; D009010:Monte Carlo Method; D009975:Orthomyxoviridae / Q000276:immunology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000191:economics / Q000517:prevention & control*; D019057:Quality-Adjusted Life Years
chemical_list: D007252:Influenza Vaccines